Top

Cancer Immunology, Immunotherapy

Published in:

01-10-2001 | Original Article

Transduction of human dendritic cells with a recombinant modified vaccinia Ankara virus encoding MUC1 and IL-2

Authors: Katrina T. Trevor, Evan M. Hersh, Jacquie Brailey, Jean-Marc Balloul, Bruce Acres

Published in: Cancer Immunology, Immunotherapy | Issue 8/2001

Title: Transduction of human dendritic cells with a recombinant modified vaccinia Ankara virus encoding MUC1 and IL-2
Authors: Katrina T. Trevor
Evan M. Hersh
Jacquie Brailey
Jean-Marc Balloul
Bruce Acres
Publication date: 01-10-2001
Publisher: Springer-Verlag
Published in: Cancer Immunology, Immunotherapy / Issue 8/2001
Print ISSN: 0340-7004
Electronic ISSN: 1432-0851
DOI: https://doi.org/10.1007/s002620100214

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

ACC 2024 Congress

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 8/2001

Target cell induced activation of NK cells in vitro: cytokine production and enhancement of cytotoxic function

Fever and cancer in perspective

Enhancement of anti-cancer immunity by a lipoteichoic-acid-related molecule isolated from a penicillin-killed group A Streptococcus

Standardized generation of fully mature p70 IL-12 secreting monocyte-derived dendritic cells for clinical use

A stable single-chain variable fragment expressing transfectoma demonstrates induction of idiotype-specific cytotoxic T-cells during early growth stages of a murine B-lymphoma

Keynote webinar | Spotlight on antibody–drug conjugates in cancer